<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38543591</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-2607</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>07</Day></PubDate></JournalIssue><Title>Microorganisms</Title><ISOAbbreviation>Microorganisms</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 and Other Respiratory Viruses in Human Olfactory Pathophysiology.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">540</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/microorganisms12030540</ELocationID><Abstract><AbstractText>Acute respiratory viruses (ARVs) are the leading cause of diseases in humans worldwide. High-risk individuals, including children and the elderly, could potentially develop severe illnesses that could result in hospitalization or death in the worst case. The most common ARVs are the Human respiratory syncytial virus, Human Metapneumovirus, Human Parainfluenza Virus, rhinovirus, coronaviruses (including SARS and MERS CoV), adenoviruses, Human Bocavirus, enterovirus (-D68 and 71), and influenza viruses. The olfactory deficits due to ARV infection are a common symptom among patients. This review provides an overview of the role of SARS-CoV-2 and other common ARVs in the development of human olfactory pathophysiology. We highlight the critical need to understand the signaling underlying the olfactory dysfunction and the development of therapeutics for this wide-ranging category of AVRs to restore the altered or loss of smell in affected patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wade</LastName><ForeName>Serigne Fallou</ForeName><Initials>SF</Initials><Identifier Source="ORCID">0000-0001-8307-0220</Identifier><AffiliationInfo><Affiliation>École Supérieure des Sciences Agricoles et de l'Alimentation, Université Amadou Makhtar MBOW, Rue 21x20, 2ème Arrondissement, Pôle Urbain de Diamniadio, Dakar P.O. Box 45927, Senegal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diouara</LastName><ForeName>Abou Abdallah Malick</ForeName><Initials>AAM</Initials><Identifier Source="ORCID">0000-0003-3658-6245</Identifier><AffiliationInfo><Affiliation>Groupe de Recherche Biotechnologies Appliquées &amp; Bioprocédés environnementaux (GRBA-BE), École Supérieure Polytechnique, Université Cheikh Anta Diop, Dakar P.O. Box 5085, Senegal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngom</LastName><ForeName>Babacar</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>École Supérieure des Sciences Agricoles et de l'Alimentation, Université Amadou Makhtar MBOW, Rue 21x20, 2ème Arrondissement, Pôle Urbain de Diamniadio, Dakar P.O. Box 45927, Senegal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thiam</LastName><ForeName>Fatou</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-8247-4426</Identifier><AffiliationInfo><Affiliation>Groupe de Recherche Biotechnologies Appliquées &amp; Bioprocédés environnementaux (GRBA-BE), École Supérieure Polytechnique, Université Cheikh Anta Diop, Dakar P.O. Box 5085, Senegal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dia</LastName><ForeName>Ndongo</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Virology Departement, Institut Pasteur de Dakar, 36, Avenue Pasteur, Dakar P.O. Box 220, Senegal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Microorganisms</MedlineTA><NlmUniqueID>101625893</NlmUniqueID><ISSNLinking>2076-2607</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">anosmia</Keyword><Keyword MajorTopicYN="N">loss of smell</Keyword><Keyword MajorTopicYN="N">olfaction disorders</Keyword><Keyword MajorTopicYN="N">respiratory viruses</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>28</Day><Hour>1</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38543591</ArticleId><ArticleId IdType="pmc">PMC10974907</ArticleId><ArticleId IdType="doi">10.3390/microorganisms12030540</ArticleId><ArticleId IdType="pii">microorganisms12030540</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu J.T., Leung K., Leung G.M. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: A modelling study. Lancet. 2020;395:689–697. doi: 10.1016/S0140-6736(20)30260-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30260-9</ArticleId><ArticleId IdType="pmc">PMC7159271</ArticleId><ArticleId IdType="pubmed">32014114</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui D.S., Azhar E.I., Madani T.A., Ntoumi F., Kock R., Dar O., Ippolito G., McHugh T.D., Memish Z.A., Drosten C., et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China. Int. J. Infect. Dis. 2020;91:264–266. doi: 10.1016/j.ijid.2020.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.01.009</ArticleId><ArticleId IdType="pmc">PMC7128332</ArticleId><ArticleId IdType="pubmed">31953166</ArticleId></ArticleIdList></Reference><Reference><Citation>Seiden A.M. Postviral olfactory loss. Otolaryngol. Clin. N. Am. 2004;37:1159–1166. doi: 10.1016/j.otc.2004.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.otc.2004.06.007</ArticleId><ArticleId IdType="pubmed">15563908</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhen Yu L., Luigi Angelo V., Paolo B.-R., Abigail W., Claire H. Post-viral olfactory loss and parosmia. BMJ Med. 2023;2:e000382. doi: 10.1136/bmjmed-2022-000382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000382</ArticleId><ArticleId IdType="pmc">PMC10568123</ArticleId><ArticleId IdType="pubmed">37841969</ArticleId></ArticleIdList></Reference><Reference><Citation>Moran D.T., Jafek B.W., Eller P.M., Rowley J.C., 3rd Ultrastructural histopathology of human olfactory dysfunction. Microsc. Res. Tech. 1992;23:103–110. doi: 10.1002/jemt.1070230202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jemt.1070230202</ArticleId><ArticleId IdType="pubmed">1421550</ArticleId></ArticleIdList></Reference><Reference><Citation>Welge-Lussen A., Wolfensberger M. Olfactory disorders following upper respiratory tract infections. Adv. Otorhinolaryngol. 2006;63:125–132. doi: 10.1159/000093758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000093758</ArticleId><ArticleId IdType="pubmed">16733337</ArticleId></ArticleIdList></Reference><Reference><Citation>Dicpinigaitis P.V. Post-viral Anosmia (Loss of Sensation of Smell) Did Not Begin with COVID-19! Lung. 2021;199:237–238. doi: 10.1007/s00408-021-00448-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00448-4</ArticleId><ArticleId IdType="pmc">PMC8067782</ArticleId><ArticleId IdType="pubmed">33893845</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J., Pinto J.M., Li L., Zhang S., Sun Z., Wei Y. Identification of Viruses in Patients with Postviral Olfactory Dysfunction by Multiplex Reverse-Transcription Polymerase Chain Reaction. Laryngoscope. 2021;131:158–164. doi: 10.1002/lary.28997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.28997</ArticleId><ArticleId IdType="pmc">PMC7436707</ArticleId><ArticleId IdType="pubmed">32786080</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki M., Saito K., Min W.P., Vladau C., Toida K., Itoh H., Murakami S. Identification of viruses in patients with postviral olfactory dysfunction. Laryngoscope. 2007;117:272–277. doi: 10.1097/01.mlg.0000249922.37381.1e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mlg.0000249922.37381.1e</ArticleId><ArticleId IdType="pmc">PMC7165544</ArticleId><ArticleId IdType="pubmed">17277621</ArticleId></ArticleIdList></Reference><Reference><Citation>Imam S.A., Lao W.P., Reddy P., Nguyen S.A., Schlosser R.J. Is SARS-CoV-2 (COVID-19) postviral olfactory dysfunction (PVOD) different from other PVOD? World J. Otorhinolaryngol. Head. Neck Surg. 2020;6((Suppl. S1)):S26–S32. doi: 10.1016/j.wjorl.2020.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wjorl.2020.05.004</ArticleId><ArticleId IdType="pmc">PMC7236684</ArticleId><ArticleId IdType="pubmed">32837756</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiura M., Aiba T., Mori J., Nakai Y. An epidemiological study of postviral olfactory disorder. Acta Otolaryngol. Suppl. 1998;538:191–196. doi: 10.1080/00016489850182918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00016489850182918</ArticleId><ArticleId IdType="pubmed">9879419</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Chiguer D.L., Tirado-Mendoza R., Marquez-Navarro A., Ambrosio-Hernandez J.R., Ruiz-Fraga I., Aguilar-Vargas R.E., Lira-Martinez J.M., Lopez-Valdes J.C. Detection and molecular characterization of respiratory viruses that cause acute respiratory infection in the adult population. Gac. Med. Mex. 2019;155((Suppl. S1)):S7–S12. doi: 10.24875/GMM.M19000282.</Citation><ArticleIdList><ArticleId IdType="doi">10.24875/GMM.M19000282</ArticleId><ArticleId IdType="pubmed">31638611</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueha R., Mukherjee S., Ueha S., de Almeida Nagata D.E., Sakamoto T., Kondo K., Yamasoba T., Lukacs N.W., Kunkel S.L. Viral disruption of olfactory progenitors is exacerbated in allergic mice. Int. Immunopharmacol. 2014;22:242–247. doi: 10.1016/j.intimp.2014.06.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2014.06.034</ArticleId><ArticleId IdType="pmc">PMC4129161</ArticleId><ArticleId IdType="pubmed">24998164</ArticleId></ArticleIdList></Reference><Reference><Citation>Heikkinen T., Jarvinen A. The common cold. Lancet. 2003;361:51–59. doi: 10.1016/S0140-6736(03)12162-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(03)12162-9</ArticleId><ArticleId IdType="pmc">PMC7112468</ArticleId><ArticleId IdType="pubmed">12517470</ArticleId></ArticleIdList></Reference><Reference><Citation>Potter M.R., Chen J.H., Lobban N.S., Doty R.L. Olfactory dysfunction from acute upper respiratory infections: Relationship to season of onset. Int. Forum Allergy Rhinol. 2020;10:706–712. doi: 10.1002/alr.22551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22551</ArticleId><ArticleId IdType="pmc">PMC7262030</ArticleId><ArticleId IdType="pubmed">32282136</ArticleId></ArticleIdList></Reference><Reference><Citation>Henrickson K.J. Parainfluenza viruses. Clin. Microbiol. Rev. 2003;16:242–264. doi: 10.1128/CMR.16.2.242-264.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.16.2.242-264.2003</ArticleId><ArticleId IdType="pmc">PMC153148</ArticleId><ArticleId IdType="pubmed">12692097</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafeek R.A.M., Divarathna M.V.M., Noordeen F. A review on disease burden and epidemiology of childhood parainfluenza virus infections in Asian countries. Rev. Med. Virol. 2021;31:e2164. doi: 10.1002/rmv.2164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2164</ArticleId><ArticleId IdType="pubmed">32996257</ArticleId></ArticleIdList></Reference><Reference><Citation>Weston S., Frieman M.B. Respiratory Viruses. In: Schmidt T.M., editor. Encyclopedia of Microbiology (Fourth Edition) Academic Press; Oxford, UK: 2019. pp. 85–101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-801238-3.66161-5</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kempen M., Bachert C., Van Cauwenberge P. An update on the pathophysiology of rhinovirus upper respiratory tract infections. Rhinology. 1999;37:97–103.</Citation><ArticleIdList><ArticleId IdType="pubmed">10567986</ArticleId></ArticleIdList></Reference><Reference><Citation>Xatzipsalti M., Kyrana S., Tsolia M., Psarras S., Bossios A., Laza-Stanca V., Johnston S.L., Papadopoulos N.G. Rhinovirus viremia in children with respiratory infections. Am. J. Respir. Crit. Care Med. 2005;172:1037–1040. doi: 10.1164/rccm.200502-315OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200502-315OC</ArticleId><ArticleId IdType="pubmed">15994468</ArticleId></ArticleIdList></Reference><Reference><Citation>Loeffelholz M.J., Trujillo R., Pyles R.B., Miller A.L., Alvarez-Fernandez P., Pong D.L., Chonmaitree T. Duration of rhinovirus shedding in the upper respiratory tract in the first year of life. Pediatrics. 2014;134:1144–1150. doi: 10.1542/peds.2014-2132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2014-2132</ArticleId><ArticleId IdType="pmc">PMC4243071</ArticleId><ArticleId IdType="pubmed">25404719</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  Severe Acute Respiratory Syndrome (SARS)  [(accessed on 3 July 2023)].  Available online:  https://www.who.int/health-topics/severe-acute-respiratory-syndrome#tab=tab_3.</Citation></Reference><Reference><Citation>de Groot R.J., Baker S.C., Baric R.S., Brown C.S., Drosten C., Enjuanes L., Fouchier R.A., Galiano M., Gorbalenya A.E., Memish Z.A., et al. Middle East respiratory syndrome coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group. J. Virol. 2013;87:7790–7792. doi: 10.1128/JVI.01244-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01244-13</ArticleId><ArticleId IdType="pmc">PMC3700179</ArticleId><ArticleId IdType="pubmed">23678167</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaki A.M., van Boheemen S., Bestebroer T.M., Osterhaus A.D., Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 2012;367:1814–1820. doi: 10.1056/NEJMoa1211721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1211721</ArticleId><ArticleId IdType="pubmed">23075143</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalafalla A.I., Lu X., Al-Mubarak A.I., Dalab A.H., Al-Busadah K.A., Erdman D.D. MERS-CoV in Upper Respiratory Tract and Lungs of Dromedary Camels, Saudi Arabia, 2013–2014. Emerg. Infect. Dis. 2015;21:1153–1158. doi: 10.3201/eid2107.150070.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2107.150070</ArticleId><ArticleId IdType="pmc">PMC4480395</ArticleId><ArticleId IdType="pubmed">26079346</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfel R., Corman V.M., Guggemos W., Seilmaier M., Zange S., Muller M.A., Niemeyer D., Jones T.C., Vollmar P., Rothe C., et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581:465–469. doi: 10.1038/s41586-020-2196-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2196-x</ArticleId><ArticleId IdType="pubmed">32235945</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo G.D., Lazarini F., Levallois S., Hautefort C., Michel V., Larrous F., Verillaud B., Aparicio C., Wagner S., Gheusi G., et al. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci. Transl. Med. 2021;13:596. doi: 10.1126/scitranslmed.abf8396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf8396</ArticleId><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>Zazhytska M., Kodra A., Hoagland D.A., Frere J., Fullard J.F., Shayya H., McArthur N.G., Moeller R., Uhl S., Omer A.D., et al. Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia. Cell. 2022;185:1052–1064.e12. doi: 10.1016/j.cell.2022.01.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.024</ArticleId><ArticleId IdType="pmc">PMC8808699</ArticleId><ArticleId IdType="pubmed">35180380</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilinska K., Butowt R. Anosmia in COVID-19: A Bumpy Road to Establishing a Cellular Mechanism. ACS Chem. Neurosci. 2020;11:2152–2155. doi: 10.1021/acschemneuro.0c00406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00406</ArticleId><ArticleId IdType="pmc">PMC7467568</ArticleId><ArticleId IdType="pubmed">32673476</ArticleId></ArticleIdList></Reference><Reference><Citation>Samaranayake L.P., Fakhruddin K.S., Panduwawala C. Sudden onset, acute loss of taste and smell in coronavirus disease 2019 (COVID-19): A systematic review. Acta Odontol. Scand. 2020;78:467–473. doi: 10.1080/00016357.2020.1787505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00016357.2020.1787505</ArticleId><ArticleId IdType="pubmed">32762282</ArticleId></ArticleIdList></Reference><Reference><Citation>Dammalli M., Dey G., Madugundu A.K., Kumar M., Rodrigues B., Gowda H., Siddaiah B.G., Mahadevan A., Shankar S.K., Prasad T.S.K. Proteomic Analysis of the Human Olfactory Bulb. OMICS. 2017;21:440–453. doi: 10.1089/omi.2017.0084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2017.0084</ArticleId><ArticleId IdType="pubmed">28816642</ArticleId></ArticleIdList></Reference><Reference><Citation>Dammalli M., Dey G., Kumar M., Madugundu A.K., Gopalakrishnan L., Gowrishankar B.S., Mahadevan A., Shankar S.K., Prasad T.S.K. Proteomics of the Human Olfactory Tract. OMICS. 2018;22:77–87. doi: 10.1089/omi.2017.0155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2017.0155</ArticleId><ArticleId IdType="pubmed">29356628</ArticleId></ArticleIdList></Reference><Reference><Citation>Oboti L., Peretto P., Marchis S.D., Fasolo A. From chemical neuroanatomy to an understanding of the olfactory system. Eur. J. Histochem. 2011;55:e35. doi: 10.4081/ejh.2011.e35.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/ejh.2011.e35</ArticleId><ArticleId IdType="pmc">PMC3284237</ArticleId><ArticleId IdType="pubmed">22297441</ArticleId></ArticleIdList></Reference><Reference><Citation>Barral-Arca R., Gomez-Carballa A., Cebey-Lopez M., Bello X., Martinon-Torres F., Salas A. A Meta-Analysis of Multiple Whole Blood Gene Expression Data Unveils a Diagnostic Host-Response Transcript Signature for Respiratory Syncytial Virus. Int. J. Mol. Sci. 2020;21:1831. doi: 10.3390/ijms21051831.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21051831</ArticleId><ArticleId IdType="pmc">PMC7084441</ArticleId><ArticleId IdType="pubmed">32155831</ArticleId></ArticleIdList></Reference><Reference><Citation>Boesveldt S., Postma E.M., Boak D., Welge-Luessen A., Schopf V., Mainland J.D., Martens J., Ngai J., Duffy V.B. Anosmia-A Clinical Review. Chem. Senses. 2017;42:513–523. doi: 10.1093/chemse/bjx025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjx025</ArticleId><ArticleId IdType="pmc">PMC5863566</ArticleId><ArticleId IdType="pubmed">28531300</ArticleId></ArticleIdList></Reference><Reference><Citation>Firestein S. How the olfactory system makes sense of scents. Nature. 2001;413:211–218. doi: 10.1038/35093026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35093026</ArticleId><ArticleId IdType="pubmed">11557990</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan P.A., Keverne E.B. Something in the air? New insights into mammalian pheromones. Curr. Biol. 2004;14:R81–R89. doi: 10.1016/j.cub.2003.12.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2003.12.052</ArticleId><ArticleId IdType="pubmed">14738757</ArticleId></ArticleIdList></Reference><Reference><Citation>Buck L.B. The molecular architecture of odor and pheromone sensing in mammals. Cell. 2000;100:611–618. doi: 10.1016/S0092-8674(00)80698-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)80698-4</ArticleId><ArticleId IdType="pubmed">10761927</ArticleId></ArticleIdList></Reference><Reference><Citation>Mombaerts P. Genes and ligands for odorant, vomeronasal and taste receptors. Nat. Rev. Neurosci. 2004;5:263–278. doi: 10.1038/nrn1365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1365</ArticleId><ArticleId IdType="pubmed">15034552</ArticleId></ArticleIdList></Reference><Reference><Citation>Restrepo D., Arellano J., Oliva A.M., Schaefer M.L., Lin W. Emerging views on the distinct but related roles of the main and accessory olfactory systems in responsiveness to chemosensory signals in mice. Horm. Behav. 2004;46:247–256. doi: 10.1016/j.yhbeh.2004.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yhbeh.2004.02.009</ArticleId><ArticleId IdType="pubmed">15325226</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavoie J., Gasso Astorga P., Segal-Gavish H., Wu Y.C., Chung Y., Cascella N.G., Sawa A., Ishizuka K. The Olfactory Neural Epithelium As a Tool in Neuroscience. Trends Mol. Med. 2017;23:100–103. doi: 10.1016/j.molmed.2016.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2016.12.010</ArticleId><ArticleId IdType="pmc">PMC5399677</ArticleId><ArticleId IdType="pubmed">28108112</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang F., Wang Y. COVID-19 Anosmia: High Prevalence, Plural Neuropathogenic Mechanisms, and Scarce Neurotropism of SARS-CoV-2? Viruses. 2021;13:2225. doi: 10.3390/v13112225.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13112225</ArticleId><ArticleId IdType="pmc">PMC8625547</ArticleId><ArticleId IdType="pubmed">34835030</ArticleId></ArticleIdList></Reference><Reference><Citation>Olender T., Lancet D., Nebert D.W. Update on the olfactory receptor (OR) gene superfamily. Hum. Genom. 2008;3:87–97. doi: 10.1186/1479-7364-3-1-87.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-7364-3-1-87</ArticleId><ArticleId IdType="pmc">PMC2752031</ArticleId><ArticleId IdType="pubmed">19129093</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurian S.M., Gordon S., Barrick B., Dadlani M.N., Fanelli B., Cornell J.B., Head S.R., Marsh C.L., Case J. Feasibility and Comparison Study of Fecal Sample Collection Methods in Healthy Volunteers and Solid Organ Transplant Recipients Using 16S rRNA and Metagenomics Approaches. Biopreserv. Biobank. 2020;18:425–440. doi: 10.1089/bio.2020.0032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/bio.2020.0032</ArticleId><ArticleId IdType="pubmed">32833508</ArticleId></ArticleIdList></Reference><Reference><Citation>Glezer I., Malnic B. Olfactory receptor function. Handb. Clin. Neurol. 2019;164:67–78. doi: 10.1016/B978-0-444-63855-7.00005-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-63855-7.00005-8</ArticleId><ArticleId IdType="pubmed">31604564</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwob J.E. Neural regeneration and the peripheral olfactory system. Anat. Rec. 2002;269:33–49. doi: 10.1002/ar.10047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ar.10047</ArticleId><ArticleId IdType="pubmed">11891623</ArticleId></ArticleIdList></Reference><Reference><Citation>Graziadei P.P., Graziadei G.A. Neurogenesis and neuron regeneration in the olfactory system of mammals. I. Morphological aspects of differentiation and structural organization of the olfactory sensory neurons. J. Neurocytol. 1979;8:1–18. doi: 10.1007/BF01206454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01206454</ArticleId><ArticleId IdType="pubmed">438867</ArticleId></ArticleIdList></Reference><Reference><Citation>Urata S., Maruyama J., Kishimoto-Urata M., Sattler R.A., Cook R., Lin N., Yamasoba T., Makishima T., Paessler S. Regeneration Profiles of Olfactory Epithelium after SARS-CoV-2 Infection in Golden Syrian Hamsters. ACS Chem. Neurosci. 2021;12:589–595. doi: 10.1021/acschemneuro.0c00649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00649</ArticleId><ArticleId IdType="pmc">PMC7874468</ArticleId><ArticleId IdType="pubmed">33522795</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D.Y., Lee W.H., Wee J.H., Kim J.W. Prognosis of postviral olfactory loss: Follow-up study for longer than one year. Am. J. Rhinol. Allergy. 2014;28:419–422. doi: 10.2500/ajra.2014.28.4102.</Citation><ArticleIdList><ArticleId IdType="doi">10.2500/ajra.2014.28.4102</ArticleId><ArticleId IdType="pubmed">25198029</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty R.L., Hawkes C.H. Chemosensory dysfunction in neurodegenerative diseases. Handb. Clin. Neurol. 2019;164:325–360. doi: 10.1016/B978-0-444-63855-7.00020-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-63855-7.00020-4</ArticleId><ArticleId IdType="pubmed">31604557</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J.H., Kwon H.J., Jang Y.J. Detection of parainfluenza virus 3 in turbinate epithelial cells of postviral olfactory dysfunction patients. Laryngoscope. 2007;117:1445–1449. doi: 10.1097/MLG.0b013e318063e878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLG.0b013e318063e878</ArticleId><ArticleId IdType="pubmed">17572640</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewandowska-Polak A., Brauncajs M., Paradowska E., Jarzebska M., Kurowski M., Moskwa S., Lesnikowski Z.J., Kowalski M.L. Human parainfluenza virus type 3 (HPIV3) induces production of IFNgamma and RANTES in human nasal epithelial cells (HNECs) J. Inflamm. 2015;12:16. doi: 10.1186/s12950-015-0054-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12950-015-0054-7</ArticleId><ArticleId IdType="pmc">PMC4342099</ArticleId><ArticleId IdType="pubmed">25722655</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori I., Komatsu T., Takeuchi K., Nakakuki K., Sudo M., Kimura Y. Parainfluenza virus type 1 infects olfactory neurons and establishes long-term persistence in the nerve tissue. Pt 5J. Gen. Virol. 1995;76:1251–1254. doi: 10.1099/0022-1317-76-5-1251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-76-5-1251</ArticleId><ArticleId IdType="pubmed">7730810</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J., Pinto J.M., Cui X., Zhang H., Li L., Liu Y., Wu C., Wei Y. Sendai Virus Induces Persistent Olfactory Dysfunction in a Murine Model of PVOD via Effects on Apoptosis, Cell Proliferation, and Response to Odorants. PLoS ONE. 2016;11:e0159033. doi: 10.1371/journal.pone.0159033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0159033</ArticleId><ArticleId IdType="pmc">PMC4948916</ArticleId><ArticleId IdType="pubmed">27428110</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C.T., Lidsky P.V., Xiao Y., Cheng R., Lee I.T., Nakayama T., Jiang S., He W., Demeter J., Knight M.G., et al. SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming. Cell. 2023;186:112–130 e120. doi: 10.1016/j.cell.2022.11.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.11.030</ArticleId><ArticleId IdType="pmc">PMC9715480</ArticleId><ArticleId IdType="pubmed">36580912</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H.S., Volpe S.J., Chang E.H. The Role of Viruses in the Inception of Chronic Rhinosinusitis. Clin. Exp. Otorhinolaryngol. 2022;15:310–318. doi: 10.21053/ceo.2022.01004.</Citation><ArticleIdList><ArticleId IdType="doi">10.21053/ceo.2022.01004</ArticleId><ArticleId IdType="pmc">PMC9723285</ArticleId><ArticleId IdType="pubmed">36455880</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J., Choudhary S., Banerjee A.K., De B.P. Human parainfluenza virus type 3 upregulates ICAM-1 (CD54) expression in a cytokine-independent manner. Gene Expr. 2000;9:115–121. doi: 10.3727/000000001783992641.</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/000000001783992641</ArticleId><ArticleId IdType="pmc">PMC5964933</ArticleId><ArticleId IdType="pubmed">11243408</ArticleId></ArticleIdList></Reference><Reference><Citation>Cieslik M., Chinnaiyan A.M. Cancer transcriptome profiling at the juncture of clinical translation. Nat. Rev. Genet. 2018;19:93–109. doi: 10.1038/nrg.2017.96.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg.2017.96</ArticleId><ArticleId IdType="pubmed">29279605</ArticleId></ArticleIdList></Reference><Reference><Citation>Worst B.C., van Tilburg C.M., Balasubramanian G.P., Fiesel P., Witt R., Freitag A., Boudalil M., Previti C., Wolf S., Schmidt S., et al. Next-generation personalised medicine for high-risk paediatric cancer patients—The INFORM pilot study. Eur. J. Cancer. 2016;65:91–101. doi: 10.1016/j.ejca.2016.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejca.2016.06.009</ArticleId><ArticleId IdType="pubmed">27479119</ArticleId></ArticleIdList></Reference><Reference><Citation>Weidenbusch B., Richter G.H.S., Kesper M.S., Guggemoos M., Gall K., Prexler C., Kazantsev I., Sipol A., Lindner L., Nathrath M., et al. Transcriptome based individualized therapy of refractory pediatric sarcomas: Feasibility, tolerability and efficacy. Oncotarget. 2018;9:20747–20760. doi: 10.18632/oncotarget.25087.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.25087</ArticleId><ArticleId IdType="pmc">PMC5945512</ArticleId><ArticleId IdType="pubmed">29755686</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsimberidou A.M., Fountzilas E., Bleris L., Kurzrock R. Transcriptomics and solid tumors: The next frontier in precision cancer medicine. Semin. Cancer Biol. 2022;84:50–59. doi: 10.1016/j.semcancer.2020.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2020.09.007</ArticleId><ArticleId IdType="pubmed">32950605</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodon J., Soria J.C., Berger R., Miller W.H., Rubin E., Kugel A., Tsimberidou A., Saintigny P., Ackerstein A., Brana I., et al. Genomic and transcriptomic profiling expands precision cancer medicine: The WINTHER trial. Nat. Med. 2019;25:751–758. doi: 10.1038/s41591-019-0424-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0424-4</ArticleId><ArticleId IdType="pmc">PMC6599610</ArticleId><ArticleId IdType="pubmed">31011205</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberg J.A., Glade Bender J.L., Sulis M.L., Pendrick D., Sireci A.N., Hsiao S.J., Turk A.T., Dela Cruz F.S., Hibshoosh H., Remotti H., et al. Implementation of next generation sequencing into pediatric hematology-oncology practice: Moving beyond actionable alterations. Genome Med. 2016;8:133. doi: 10.1186/s13073-016-0389-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-016-0389-6</ArticleId><ArticleId IdType="pmc">PMC5180407</ArticleId><ArticleId IdType="pubmed">28007021</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas De Lamballerie C., Pizzorno A., Dubois J., Padey B., Julien T., Traversier A., Carbonneau J., Orcel E., Lina B., Hamelin M.E., et al. Human Respiratory Syncytial Virus-Induced Immune Signature of Infection Revealed by Transcriptome Analysis of Clinical Pediatric Nasopharyngeal Swab Samples. J. Infect. Dis. 2021;223:1052–1061. doi: 10.1093/infdis/jiaa468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa468</ArticleId><ArticleId IdType="pmc">PMC8006426</ArticleId><ArticleId IdType="pubmed">32726438</ArticleId></ArticleIdList></Reference><Reference><Citation>Dissanayake T.K., Schauble S., Mirhakkak M.H., Wu W.L., Ng A.C., Yip C.C.Y., Lopez A.G., Wolf T., Yeung M.L., Chan K.H., et al. Comparative Transcriptomic Analysis of Rhinovirus and Influenza Virus Infection. Front. Microbiol. 2020;11:1580. doi: 10.3389/fmicb.2020.01580.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01580</ArticleId><ArticleId IdType="pmc">PMC7396524</ArticleId><ArticleId IdType="pubmed">32849329</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Shalan H.A.M., Hu D., Wang P., Uddin J., Chopra A., Greene W.K., Ma B. Transcriptomic Profiling of Influenza A Virus-Infected Mouse Lung at Recovery Stage Using RNA Sequencing. Viruses. 2023;15:2198. doi: 10.3390/v15112198.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15112198</ArticleId><ArticleId IdType="pmc">PMC10675624</ArticleId><ArticleId IdType="pubmed">38005876</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryche B., Fretaud M., Saint-Albin Deliot A., Galloux M., Sedano L., Langevin C., Descamps D., Rameix-Welti M.A., Eleouet J.F., Le Goffic R., et al. Respiratory syncytial virus tropism for olfactory sensory neurons in mice. J. Neurochem. 2020;155:137–153. doi: 10.1111/jnc.14936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14936</ArticleId><ArticleId IdType="pubmed">31811775</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths C.D., Bilawchuk L.M., McDonough J.E., Jamieson K.C., Elawar F., Cen Y., Duan W., Lin C., Song H., Casanova J.L., et al. IGF1R is an entry receptor for respiratory syncytial virus. Nature. 2020;583:615–619. doi: 10.1038/s41586-020-2369-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2369-7</ArticleId><ArticleId IdType="pubmed">32494007</ArticleId></ArticleIdList></Reference><Reference><Citation>Tayyari F., Marchant D., Moraes T.J., Duan W., Mastrangelo P., Hegele R.G. Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat. Med. 2011;17:1132–1135. doi: 10.1038/nm.2444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2444</ArticleId><ArticleId IdType="pubmed">21841784</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrangelo P., Chin A.A., Tan S., Jeon A.H., Ackerley C.A., Siu K.K., Lee J.E., Hegele R.G. Identification of RSV Fusion Protein Interaction Domains on the Virus Receptor, Nucleolin. Viruses. 2021;13:261. doi: 10.3390/v13020261.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020261</ArticleId><ArticleId IdType="pmc">PMC7915953</ArticleId><ArticleId IdType="pubmed">33567674</ArticleId></ArticleIdList></Reference><Reference><Citation>Sourimant J., Lieber C.M., Aggarwal M., Cox R.M., Wolf J.D., Yoon J.J., Toots M., Ye C., Sticher Z., Kolykhalov A.A., et al. 4′-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication. Science. 2022;375:161–167. doi: 10.1126/science.abj5508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj5508</ArticleId><ArticleId IdType="pmc">PMC9206510</ArticleId><ArticleId IdType="pubmed">34855509</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H.H., Xu J., He L., Denny L.I., Rustandi R.R., Dornadula G., Fiorito B., Zhang Z.Q. Development and qualification of cell-based relative potency assay for a human respiratory syncytial virus (RSV) mRNA vaccine. J. Pharm. Biomed. Anal. 2023;234:115523. doi: 10.1016/j.jpba.2023.115523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpba.2023.115523</ArticleId><ArticleId IdType="pubmed">37336039</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker J.A., Sahly H.M.E., Healy C.M. mRNA vaccines against respiratory viruses. Curr. Opin. Infect. Dis. 2023;36:385–393. doi: 10.1097/QCO.0000000000000948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000948</ArticleId><ArticleId IdType="pubmed">37462930</ArticleId></ArticleIdList></Reference><Reference><Citation>Bochkov Y.A., Watters K., Ashraf S., Griggs T.F., Devries M.K., Jackson D.J., Palmenberg A.C., Gern J.E. Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication. Proc. Natl. Acad. Sci. USA. 2015;112:5485–5490. doi: 10.1073/pnas.1421178112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1421178112</ArticleId><ArticleId IdType="pmc">PMC4418890</ArticleId><ArticleId IdType="pubmed">25848009</ArticleId></ArticleIdList></Reference><Reference><Citation>Staunton D.E., Merluzzi V.J., Rothlein R., Barton R., Marlin S.D., Springer T.A. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell. 1989;56:849–853. doi: 10.1016/0092-8674(89)90689-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(89)90689-2</ArticleId><ArticleId IdType="pubmed">2538244</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofer F., Gruenberger M., Kowalski H., Machat H., Huettinger M., Kuechler E., Blaas D. Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus. Proc. Natl. Acad. Sci. USA. 1994;91:1839–1842. doi: 10.1073/pnas.91.5.1839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.5.1839</ArticleId><ArticleId IdType="pmc">PMC43259</ArticleId><ArticleId IdType="pubmed">8127891</ArticleId></ArticleIdList></Reference><Reference><Citation>Bochkov Y.A., Gern J.E. Rhinoviruses and Their Receptors: Implications for Allergic Disease. Curr. Allergy Asthma Rep. 2016;16:30. doi: 10.1007/s11882-016-0608-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11882-016-0608-7</ArticleId><ArticleId IdType="pmc">PMC4854667</ArticleId><ArticleId IdType="pubmed">26960297</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.H., Han M.S., Lee T.H., Lee D.B., Park J.H., Lee S.H., Kim T.H. Hydrogen peroxide attenuates rhinovirus-induced anti-viral interferon secretion in sinonasal epithelial cells. Front. Immunol. 2023;14:1086381. doi: 10.3389/fimmu.2023.1086381.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1086381</ArticleId><ArticleId IdType="pmc">PMC9968966</ArticleId><ArticleId IdType="pubmed">36860857</ArticleId></ArticleIdList></Reference><Reference><Citation>Torabi A., Mohammadbagheri E., Akbari Dilmaghani N., Bayat A.H., Fathi M., Vakili K., Alizadeh R., Rezaeimirghaed O., Hajiesmaeili M., Ramezani M., et al. Proinflammatory Cytokines in the Olfactory Mucosa Result in COVID-19 Induced Anosmia. ACS Chem. Neurosci. 2020;11:1909–1913. doi: 10.1021/acschemneuro.0c00249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00249</ArticleId><ArticleId IdType="pubmed">32525657</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J., Wong L.R., Li K., Verma A.K., Ortiz M.E., Wohlford-Lenane C., Leidinger M.R., Knudson C.M., Meyerholz D.K., McCray P.B., Jr., et al. COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice. Nature. 2021;589:603–607. doi: 10.1038/s41586-020-2943-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2943-z</ArticleId><ArticleId IdType="pmc">PMC7855185</ArticleId><ArticleId IdType="pubmed">33166988</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilinska K., Jakubowska P., Von Bartheld C.S., Butowt R. Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age. ACS Chem. Neurosci. 2020;11:1555–1562. doi: 10.1021/acschemneuro.0c00210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00210</ArticleId><ArticleId IdType="pmc">PMC7241737</ArticleId><ArticleId IdType="pubmed">32379417</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies J., Randeva H.S., Chatha K., Hall M., Spandidos D.A., Karteris E., Kyrou I. Neuropilin-1 as a new potential SARS-CoV-2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID-19. Mol. Med. Rep. 2020;22:4221–4226. doi: 10.3892/mmr.2020.11510.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2020.11510</ArticleId><ArticleId IdType="pmc">PMC7533503</ArticleId><ArticleId IdType="pubmed">33000221</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang Y.L., Chou Y.Y., Rothlauf P.W., Liu Z., Soh T.K., Cureton D., Case J.B., Chen R.E., Diamond M.S., Whelan S.P.J., et al. Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2. Proc. Natl. Acad. Sci. USA. 2020;117:20803–20813. doi: 10.1073/pnas.2007837117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2007837117</ArticleId><ArticleId IdType="pmc">PMC7456157</ArticleId><ArticleId IdType="pubmed">32764148</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayi B.S., Leibowitz J.A., Woods A.T., Ammon K.A., Liu A.E., Raja A. The role of Neuropilin-1 in COVID-19. PLoS Pathog. 2021;17:e1009153. doi: 10.1371/journal.ppat.1009153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009153</ArticleId><ArticleId IdType="pmc">PMC7781380</ArticleId><ArticleId IdType="pubmed">33395426</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryche B., St Albin A., Murri S., Lacote S., Pulido C., Ar Gouilh M., Lesellier S., Servat A., Wasniewski M., Picard-Meyer E., et al. Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters. Brain Behav. Immun. 2020;89:579–586. doi: 10.1016/j.bbi.2020.06.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.06.032</ArticleId><ArticleId IdType="pmc">PMC7332942</ArticleId><ArticleId IdType="pubmed">32629042</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantuti-Castelvetri L., Ojha R., Pedro L.D., Djannatian M., Franz J., Kuivanen S., van der Meer F., Kallio K., Kaya T., Anastasina M., et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020;370:856–860. doi: 10.1126/science.abd2985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd2985</ArticleId><ArticleId IdType="pmc">PMC7857391</ArticleId><ArticleId IdType="pubmed">33082293</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly J.L., Simonetti B., Klein K., Chen K.E., Williamson M.K., Anton-Plagaro C., Shoemark D.K., Simon-Gracia L., Bauer M., Hollandi R., et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science. 2020;370:861–865. doi: 10.1126/science.abd3072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd3072</ArticleId><ArticleId IdType="pmc">PMC7612957</ArticleId><ArticleId IdType="pubmed">33082294</ArticleId></ArticleIdList></Reference><Reference><Citation>Acevedo C., Blanchard K., Bacigalupo J., Vergara C. Possible ATP trafficking by ATP-shuttles in the olfactory cilia and glucose transfer across the olfactory mucosa. FEBS Lett. 2019;593:601–610. doi: 10.1002/1873-3468.13346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.13346</ArticleId><ArticleId IdType="pubmed">30801684</ArticleId></ArticleIdList></Reference><Reference><Citation>Villar P.S., Vergara C., Bacigalupo J. Energy sources that fuel metabolic processes in protruding finger-like organelles. FEBS J. 2021;288:3799–3812. doi: 10.1111/febs.15620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15620</ArticleId><ArticleId IdType="pubmed">33142020</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan S., Nordqvist H., Ambikan A.T., Gupta S., Sperk M., Svensson-Akusjarvi S., Mikaeloff F., Benfeitas R., Saccon E., Ponnan S.M., et al. Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication. Mol. Cell Proteom. 2021;20:100159. doi: 10.1016/j.mcpro.2021.100159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcpro.2021.100159</ArticleId><ArticleId IdType="pmc">PMC8490130</ArticleId><ArticleId IdType="pubmed">34619366</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M., Yoo S.J., Clijsters M., Backaert W., Vanstapel A., Speleman K., Lietaer C., Choi S., Hether T.D., Marcelis L., et al. Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb. Cell. 2021;184:5932–5949 e5915. doi: 10.1016/j.cell.2021.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.10.027</ArticleId><ArticleId IdType="pmc">PMC8564600</ArticleId><ArticleId IdType="pubmed">34798069</ArticleId></ArticleIdList></Reference><Reference><Citation>Assou S., Ahmed E., Morichon L., Nasri A., Foisset F., Bourdais C., Gros N., Tieo S., Petit A., Vachier I., et al. The Transcriptome Landscape of the In Vitro Human Airway Epithelium Response to SARS-CoV-2. Int. J. Mol. Sci. 2023;24:12017. doi: 10.3390/ijms241512017.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241512017</ArticleId><ArticleId IdType="pmc">PMC10418806</ArticleId><ArticleId IdType="pubmed">37569398</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavoie T.B., Kalie E., Crisafulli-Cabatu S., Abramovich R., DiGioia G., Moolchan K., Pestka S., Schreiber G. Binding and activity of all human alpha interferon subtypes. Cytokine. 2011;56:282–289. doi: 10.1016/j.cyto.2011.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2011.07.019</ArticleId><ArticleId IdType="pubmed">21856167</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaks E., Gavutis M., Uze G., Martal J., Piehler J. Differential receptor subunit affinities of type I interferons govern differential signal activation. J. Mol. Biol. 2007;366:525–539. doi: 10.1016/j.jmb.2006.11.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2006.11.053</ArticleId><ArticleId IdType="pubmed">17174979</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly R.P., Sheikh F., Kotenko S.V., Dickensheets H. The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J. Leukoc. Biol. 2004;76:314–321. doi: 10.1189/jlb.0204117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0204117</ArticleId><ArticleId IdType="pubmed">15123776</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Ninaber D.K., van Schadewijk A., Hiemstra P.S. Tiotropium and Fluticasone Inhibit Rhinovirus-Induced Mucin Production via Multiple Mechanisms in Differentiated Airway Epithelial Cells. Front. Cell Infect. Microbiol. 2020;10:278. doi: 10.3389/fcimb.2020.00278.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.00278</ArticleId><ArticleId IdType="pmc">PMC7318795</ArticleId><ArticleId IdType="pubmed">32637364</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo D., Kennedy J.L., Kurten R.C., Panettieri R.A., Jr., Koziol-White C.J. Modulation of airway hyperresponsiveness by rhinovirus exposure. Respir. Res. 2018;19:208. doi: 10.1186/s12931-018-0914-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-018-0914-9</ArticleId><ArticleId IdType="pmc">PMC6206673</ArticleId><ArticleId IdType="pubmed">30373568</ArticleId></ArticleIdList></Reference><Reference><Citation>Loxham M., Smart D.E., Bedke N.J., Smithers N.P., Filippi I., Blume C., Swindle E.J., Tariq K., Howarth P.H., Holgate S.T., et al. Allergenic proteases cleave the chemokine CX3CL1 directly from the surface of airway epithelium and augment the effect of rhinovirus. Mucosal Immunol. 2018;11:404–414. doi: 10.1038/mi.2017.63.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2017.63</ArticleId><ArticleId IdType="pubmed">28677664</ArticleId></ArticleIdList></Reference><Reference><Citation>Papi A., Papadopoulos N.G., Stanciu L.A., Bellettato C.M., Pinamonti S., Degitz K., Holgate S.T., Johnston S.L. Reducing agents inhibit rhinovirus-induced up-regulation of the rhinovirus receptor intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells. FASEB J. 2002;16:1934–1936. doi: 10.1096/fj.02-0118fje.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.02-0118fje</ArticleId><ArticleId IdType="pubmed">12368227</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y.P., Tang M.F., Leung A.S.Y., Tao K.P., Chan O.M., Wong G.W.K., Chan P.K.S., Chan R.W.Y., Leung T.F. Interactive effects between CDHR3 genotype and rhinovirus species for diagnosis and severity of respiratory tract infections in hospitalized children. Microbiol. Spectr. 2023;11:e0118123. doi: 10.1128/spectrum.01181-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01181-23</ArticleId><ArticleId IdType="pmc">PMC10581227</ArticleId><ArticleId IdType="pubmed">37750685</ArticleId></ArticleIdList></Reference><Reference><Citation>Greiller C.L., Suri R., Jolliffe D.A., Kebadze T., Hirsman A.G., Griffiths C.J., Johnston S.L., Martineau A.R. Vitamin D attenuates rhinovirus-induced expression of intercellular adhesion molecule-1 (ICAM-1) and platelet-activating factor receptor (PAFR) in respiratory epithelial cells. J. Steroid Biochem. Mol. Biol. 2019;187:152–159. doi: 10.1016/j.jsbmb.2018.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2018.11.013</ArticleId><ArticleId IdType="pubmed">30476590</ArticleId></ArticleIdList></Reference><Reference><Citation>Khani E., Khiali S., Beheshtirouy S., Entezari-Maleki T. Potential pharmacologic treatments for COVID-19 smell and taste loss: A comprehensive review. Eur. J. Pharmacol. 2021;912:174582. doi: 10.1016/j.ejphar.2021.174582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2021.174582</ArticleId><ArticleId IdType="pmc">PMC8524700</ArticleId><ArticleId IdType="pubmed">34678243</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva Andrade B., Siqueira S., de Assis Soares W.R., de Souza Rangel F., Santos N.O., Dos Santos Freitas A., Ribeiro da Silveira P., Tiwari S., Alzahrani K.J., Goes-Neto A., et al. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses. 2021;13:700. doi: 10.3390/v13040700.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13040700</ArticleId><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C., Cancela-Cilleruelo I., Rodriguez-Jimenez J., Gomez-Mayordomo V., Pellicer-Valero O.J., Martin-Guerrero J.D., Hernandez-Barrera V., Arendt-Nielsen L., Torres-Macho J. Associated-Onset Symptoms and Post-COVID-19 Symptoms in Hospitalized COVID-19 Survivors Infected with Wuhan, Alpha or Delta SARS-CoV-2 Variant. Pathogens. 2022;11:725. doi: 10.3390/pathogens11070725.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11070725</ArticleId><ArticleId IdType="pmc">PMC9320021</ArticleId><ArticleId IdType="pubmed">35889971</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Sevilla J.J., Guerri-Fernadez R., Bertran Recasens B. Is There Less Alteration of Smell Sensation in Patients with Omicron SARS-CoV-2 Variant Infection? Front Med. 2022;9:852998. doi: 10.3389/fmed.2022.852998.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.852998</ArticleId><ArticleId IdType="pmc">PMC9039252</ArticleId><ArticleId IdType="pubmed">35492353</ArticleId></ArticleIdList></Reference><Reference><Citation>Chee J., Chern B., Loh W.S., Mullol J., Wang Y. Pathophysiology of SARS-CoV-2 Infection of Nasal Respiratory and Olfactory Epithelia and Its Clinical Impact. Curr. Allergy Asthma Rep. 2023;23:121–131. doi: 10.1007/s11882-022-01059-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11882-022-01059-6</ArticleId><ArticleId IdType="pmc">PMC9811886</ArticleId><ArticleId IdType="pubmed">36598732</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutiawati E., Fahriani M., Mamada S.S., Fajar J.K., Frediansyah A., Maliga H.A., Ilmawan M., Emran T.B., Ophinni Y., Ichsan I., et al. Anosmia and dysgeusia in SARS-CoV-2 infection: Incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms—A systematic review and meta-analysis. F1000Res. 2021;10:40. doi: 10.12688/f1000research.28393.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.28393.1</ArticleId><ArticleId IdType="pmc">PMC7993408</ArticleId><ArticleId IdType="pubmed">33824716</ArticleId></ArticleIdList></Reference><Reference><Citation>Butowt R., von Bartheld C.S. Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection. Neuroscientist. 2021;27:582–603. doi: 10.1177/1073858420956905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858420956905</ArticleId><ArticleId IdType="pmc">PMC7488171</ArticleId><ArticleId IdType="pubmed">32914699</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra R.S., Dhanjal J.K., Meena A.S., Kalel V.C., Dahiya S., Singh B., Dewanjee S., Kandimalla R. COVID-19, Neuropathology, and Aging: SARS-CoV-2 Neurological Infection, Mechanism, and Associated Complications. Front. Aging Neurosci. 2021;13:662786. doi: 10.3389/fnagi.2021.662786.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.662786</ArticleId><ArticleId IdType="pmc">PMC8209245</ArticleId><ArticleId IdType="pubmed">34149397</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebholz H., Braun R.J., Ladage D., Knoll W., Kleber C., Hassel A.W. Loss of Olfactory Function-Early Indicator for COVID-19, Other Viral Infections and Neurodegenerative Disorders. Front. Neurol. 2020;11:569333. doi: 10.3389/fneur.2020.569333.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.569333</ArticleId><ArticleId IdType="pmc">PMC7649754</ArticleId><ArticleId IdType="pubmed">33193009</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyna R.A., Kishimoto-Urata M., Urata S., Makishima T., Paessler S., Maruyama J. Recovery of anosmia in hamsters infected with SARS-CoV-2 is correlated with repair of the olfactory epithelium. Sci. Rep. 2022;12:628. doi: 10.1038/s41598-021-04622-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-04622-9</ArticleId><ArticleId IdType="pmc">PMC8755745</ArticleId><ArticleId IdType="pubmed">35022504</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanzadehpanah H., Lotfian E., Avan A., Saki S., Nobari S., Mahmoodian R., Sheykhhasan M., Froutagh M.H.S., Ghotbani F., Jamshidi R., et al. Role of SARS-CoV-2 and ACE2 in the pathophysiology of peripheral vascular diseases. Biomed. Pharmacother. 2023;166:115321. doi: 10.1016/j.biopha.2023.115321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2023.115321</ArticleId><ArticleId IdType="pubmed">37597321</ArticleId></ArticleIdList></Reference><Reference><Citation>Butowt R., Bilinska K., von Bartheld C.S. Olfactory dysfunction in COVID-19: New insights into the underlying mechanisms. Trends Neurosci. 2023;46:75–90. doi: 10.1016/j.tins.2022.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2022.11.003</ArticleId><ArticleId IdType="pmc">PMC9666374</ArticleId><ArticleId IdType="pubmed">36470705</ArticleId></ArticleIdList></Reference><Reference><Citation>Buqaileh R., Saternos H., Ley S., Aranda A., Forero K., AbouAlaiwi W.A. Can cilia provide an entry gateway for SARS-CoV-2 to human ciliated cells? Physiol. Genom. 2021;53:249–258. doi: 10.1152/physiolgenomics.00015.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiolgenomics.00015.2021</ArticleId><ArticleId IdType="pmc">PMC8213509</ArticleId><ArticleId IdType="pubmed">33855870</ArticleId></ArticleIdList></Reference><Reference><Citation>Butowt R., Meunier N., Bryche B., von Bartheld C.S. The olfactory nerve is not a likely route to brain infection in COVID-19: A critical review of data from humans and animal models. Acta Neuropathol. 2021;141:809–822. doi: 10.1007/s00401-021-02314-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-021-02314-2</ArticleId><ArticleId IdType="pmc">PMC8075028</ArticleId><ArticleId IdType="pubmed">33903954</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Chiesa-Estomba C.M., De Siati D.R., Horoi M., Le Bon S.D., Rodriguez A., Dequanter D., Blecic S., El Afia F., Distinguin L., et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study. Eur. Arch. Otorhinolaryngol. 2020;277:2251–2261. doi: 10.1007/s00405-020-05965-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-05965-1</ArticleId><ArticleId IdType="pmc">PMC7134551</ArticleId><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y., Min P., Lee S., Kim S.W. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients. J. Korean Med. Sci. 2020;35:e174. doi: 10.3346/jkms.2020.35.e174.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2020.35.e174</ArticleId><ArticleId IdType="pmc">PMC7211515</ArticleId><ArticleId IdType="pubmed">32383370</ArticleId></ArticleIdList></Reference><Reference><Citation>Fodoulian L., Tuberosa J., Rossier D., Boillat M., Kan C., Pauli V., Egervari K., Lobrinus J.A., Landis B.N., Carleton A., et al. SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain. iScience. 2020;23:101839. doi: 10.1016/j.isci.2020.101839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101839</ArticleId><ArticleId IdType="pmc">PMC7685946</ArticleId><ArticleId IdType="pubmed">33251489</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M., Shen W., Rowan N.R., Kulaga H., Hillel A., Ramanathan M., Jr., Lane A.P. Elevated ACE-2 expression in the olfactory neuroepithelium: Implications for anosmia and upper respiratory SARS-CoV-2 entry and replication. Eur. Respir. J. 2020;56:2001948. doi: 10.1183/13993003.01948-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01948-2020</ArticleId><ArticleId IdType="pmc">PMC7439429</ArticleId><ArticleId IdType="pubmed">32817004</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kruger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271–280 e278. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler C.G.K., Allon S.J., Nyquist S.K., Mbano I.M., Miao V.N., Tzouanas C.N., Cao Y., Yousif A.S., Bals J., Hauser B.M., et al. SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. Cell. 2020;181:1016–1035.e1019. doi: 10.1016/j.cell.2020.04.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.035</ArticleId><ArticleId IdType="pmc">PMC7252096</ArticleId><ArticleId IdType="pubmed">32413319</ArticleId></ArticleIdList></Reference><Reference><Citation>Gkogkou E., Barnasas G., Vougas K., Trougakos I.P. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators. Redox Biol. 2020;36:101615. doi: 10.1016/j.redox.2020.101615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2020.101615</ArticleId><ArticleId IdType="pmc">PMC7311357</ArticleId><ArticleId IdType="pubmed">32863223</ArticleId></ArticleIdList></Reference><Reference><Citation>Sungnak W., Huang N., Becavin C., Berg M., Queen R., Litvinukova M., Talavera-Lopez C., Maatz H., Reichart D., Sampaziotis F., et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat. Med. 2020;26:681–687. doi: 10.1038/s41591-020-0868-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0868-6</ArticleId><ArticleId IdType="pmc">PMC8637938</ArticleId><ArticleId IdType="pubmed">32327758</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Li M., Ou G. COVID-19, cilia, and smell. FEBS J. 2020;287:3672–3676. doi: 10.1111/febs.15491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15491</ArticleId><ArticleId IdType="pmc">PMC7426555</ArticleId><ArticleId IdType="pubmed">32692465</ArticleId></ArticleIdList></Reference><Reference><Citation>Sternberg A., Naujokat C. Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination. Life Sci. 2020;257:118056. doi: 10.1016/j.lfs.2020.118056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.118056</ArticleId><ArticleId IdType="pmc">PMC7336130</ArticleId><ArticleId IdType="pubmed">32645344</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M., Pekosz A., Villano J.S., Shen W., Zhou R., Kulaga H., Li Z., Beck S.E., Witwer K.W., Mankowski J.L., et al. Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants. bioRxiv. 2022 doi: 10.1101/2022.04.12.487379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.04.12.487379</ArticleId><ArticleId IdType="pmc">PMC11014658</ArticleId><ArticleId IdType="pubmed">38483537</ArticleId></ArticleIdList></Reference><Reference><Citation>von Bartheld C.S., Wang L. Prevalence of Olfactory Dysfunction with the Omicron Variant of SARS-CoV-2: A Systematic Review and Meta-Analysis. Cells. 2023;12:430. doi: 10.3390/cells12030430.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12030430</ArticleId><ArticleId IdType="pmc">PMC9913864</ArticleId><ArticleId IdType="pubmed">36766771</ArticleId></ArticleIdList></Reference><Reference><Citation>von Bartheld C.S., Hagen M.M., Butowt R. The D614G Virus Mutation Enhances Anosmia in COVID-19 Patients: Evidence from a Systematic Review and Meta-analysis of Studies from South Asia. ACS Chem. Neurosci. 2021;12:3535–3549. doi: 10.1021/acschemneuro.1c00542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.1c00542</ArticleId><ArticleId IdType="pmc">PMC8482322</ArticleId><ArticleId IdType="pubmed">34533304</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiner T., Allnoch L., Beythien G., Marek K., Becker K., Schaudien D., Stanelle-Bertram S., Schaumburg B., Mounogou Kouassi N., Beck S., et al. SARS-CoV-2 Infection Dysregulates Cilia and Basal Cell Homeostasis in the Respiratory Epithelium of Hamsters. Int. J. Mol. Sci. 2022;23:5124. doi: 10.3390/ijms23095124.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23095124</ArticleId><ArticleId IdType="pmc">PMC9102945</ArticleId><ArticleId IdType="pubmed">35563514</ArticleId></ArticleIdList></Reference><Reference><Citation>Seehusen F., Clark J.J., Sharma P., Bentley E.G., Kirby A., Subramaniam K., Wunderlin-Giuliani S., Hughes G.L., Patterson E.I., Michael B.D., et al. Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse. Viruses. 2022;14:1020. doi: 10.3390/v14051020.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14051020</ArticleId><ArticleId IdType="pmc">PMC9146514</ArticleId><ArticleId IdType="pubmed">35632761</ArticleId></ArticleIdList></Reference><Reference><Citation>Trobaugh D.W., Klimstra W.B. MicroRNA Regulation of RNA Virus Replication and Pathogenesis. Trends Mol. Med. 2017;23:80–93. doi: 10.1016/j.molmed.2016.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2016.11.003</ArticleId><ArticleId IdType="pmc">PMC5836316</ArticleId><ArticleId IdType="pubmed">27989642</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna J., Hossain G.S., Kocerha J. The Potential for microRNA Therapeutics and Clinical Research. Front. Genet. 2019;10:478. doi: 10.3389/fgene.2019.00478.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2019.00478</ArticleId><ArticleId IdType="pmc">PMC6532434</ArticleId><ArticleId IdType="pubmed">31156715</ArticleId></ArticleIdList></Reference><Reference><Citation>Osan J.K., DeMontigny B.A., Mehedi M. Immunohistochemistry for protein detection in PFA-fixed paraffin-embedded SARS-CoV-2-infected COPD airway epithelium. STAR Protoc. 2021;2:100663. doi: 10.1016/j.xpro.2021.100663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xpro.2021.100663</ArticleId><ArticleId IdType="pmc">PMC8259228</ArticleId><ArticleId IdType="pubmed">34250510</ArticleId></ArticleIdList></Reference><Reference><Citation>Trifonova I., Christova I., Madzharova I., Angelova S., Voleva S., Yordanova R., Tcherveniakova T., Krumova S., Korsun N. Clinical significance and role of coinfections with respiratory pathogens among individuals with confirmed severe acute respiratory syndrome coronavirus-2 infection. Front. Public. Health. 2022;10:959319. doi: 10.3389/fpubh.2022.959319.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.959319</ArticleId><ArticleId IdType="pmc">PMC9479447</ArticleId><ArticleId IdType="pubmed">36117597</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohde G., Wiethege A., Borg I., Kauth M., Bauer T.T., Gillissen A., Bufe A., Schultze-Werninghaus G. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: A case-control study. Thorax. 2003;58:37–42. doi: 10.1136/thorax.58.1.37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thorax.58.1.37</ArticleId><ArticleId IdType="pmc">PMC1746460</ArticleId><ArticleId IdType="pubmed">12511718</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Choi S.M., Lee J., Park Y.S., Lee C.H., Yim J.J., Yoo C.G., Kim Y.W., Han S.K., Lee S.M. Respiratory virus of severe pneumonia in South Korea: Prevalence and clinical implications. PLoS ONE. 2018;13:e0198902. doi: 10.1371/journal.pone.0198902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0198902</ArticleId><ArticleId IdType="pmc">PMC6005478</ArticleId><ArticleId IdType="pubmed">29912989</ArticleId></ArticleIdList></Reference><Reference><Citation>Olloquequi J. COVID-19 Susceptibility in chronic obstructive pulmonary disease. Eur. J. Clin. Investig. 2020;50:e13382. doi: 10.1111/eci.13382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13382</ArticleId><ArticleId IdType="pmc">PMC7435530</ArticleId><ArticleId IdType="pubmed">32780415</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhumaid S., Al Mutair A., Al Alawi Z., Alshawi A.M., Alomran S.A., Almuhanna M.S., Almuslim A.A., Bu Shafia A.H., Alotaibi A.M., Ahmed G.Y., et al. Coinfections with Bacteria, Fungi, and Respiratory Viruses in Patients with SARS-CoV-2: A Systematic Review and Meta-Analysis. Pathogens. 2021;10:809. doi: 10.3390/pathogens10070809.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10070809</ArticleId><ArticleId IdType="pmc">PMC8308492</ArticleId><ArticleId IdType="pubmed">34202114</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooksey G.L.S., Morales C., Linde L., Schildhauer S., Guevara H., Chan E., Gibb K., Wong J., Lin W., Bonin B.J., et al. Severe Acute Respiratory Syndrome Coronavirus 2 and Respiratory Virus Sentinel Surveillance, California, USA, May 10, 2020-June 12, 2021. Emerg. Infect. Dis. 2022;28:9–19. doi: 10.3201/eid2801.211682.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2801.211682</ArticleId><ArticleId IdType="pmc">PMC8714231</ArticleId><ArticleId IdType="pubmed">34932449</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong S., Lee N., Park Y., Kim J., Jeon K., Park M.J., Song W. Prevalence and Clinical Impact of Coinfection in Patients with Coronavirus Disease 2019 in Korea. Viruses. 2022;14:446. doi: 10.3390/v14020446.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14020446</ArticleId><ArticleId IdType="pmc">PMC8876760</ArticleId><ArticleId IdType="pubmed">35216039</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D., Quinn J., Pinsky B., Shah N.H., Brown I. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens. JAMA. 2020;323:2085–2086. doi: 10.1001/jama.2020.6266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6266</ArticleId><ArticleId IdType="pmc">PMC7160748</ArticleId><ArticleId IdType="pubmed">32293646</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowak M.D., Sordillo E.M., Gitman M.R., Paniz Mondolfi A.E. Coinfection in SARS-CoV-2 infected patients: Where are influenza virus and rhinovirus/enterovirus? J. Med. Virol. 2020;92:1699–1700. doi: 10.1002/jmv.25953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25953</ArticleId><ArticleId IdType="pmc">PMC7267652</ArticleId><ArticleId IdType="pubmed">32352574</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrel S., Hausfater P., Dres M., Pourcher V., Luyt C.E., Teyssou E., Soulie C., Calvez V., Marcelin A.G., Boutolleau D. Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19. Int. J. Infect. Dis. 2021;102:10–13. doi: 10.1016/j.ijid.2020.10.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.040</ArticleId><ArticleId IdType="pmc">PMC7585729</ArticleId><ArticleId IdType="pubmed">33115679</ArticleId></ArticleIdList></Reference><Reference><Citation>Nainwal N. Treatment of respiratory viral infections through inhalation therapeutics: Challenges and opportunities. Pulm. Pharmacol. Ther. 2022;77:102170. doi: 10.1016/j.pupt.2022.102170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pupt.2022.102170</ArticleId><ArticleId IdType="pmc">PMC9554202</ArticleId><ArticleId IdType="pubmed">36240985</ArticleId></ArticleIdList></Reference><Reference><Citation>Melgar M., Britton A., Roper L.E., Talbot H.K., Long S.S., Kotton C.N., Havers F.P. Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices—United States, 2023. MMWR Morb. Mortal. Wkly. Rep. 2023;72:793–801. doi: 10.15585/mmwr.mm7229a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7229a4</ArticleId><ArticleId IdType="pmc">PMC10360650</ArticleId><ArticleId IdType="pubmed">37471262</ArticleId></ArticleIdList></Reference><Reference><Citation>Tregoning J.S., Schwarze J. Respiratory viral infections in infants: Causes, clinical symptoms, virology, and immunology. Clin. Microbiol. Rev. 2010;23:74–98. doi: 10.1128/CMR.00032-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00032-09</ArticleId><ArticleId IdType="pmc">PMC2806659</ArticleId><ArticleId IdType="pubmed">20065326</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths C., Drews S.J., Marchant D.J. Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment. Clin. Microbiol. Rev. 2017;30:277–319. doi: 10.1128/CMR.00010-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00010-16</ArticleId><ArticleId IdType="pmc">PMC5217795</ArticleId><ArticleId IdType="pubmed">27903593</ArticleId></ArticleIdList></Reference><Reference><Citation>Coultas J.A., Smyth R., Openshaw P.J. Respiratory syncytial virus (RSV): A scourge from infancy to old age. Thorax. 2019;74:986–993. doi: 10.1136/thoraxjnl-2018-212212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2018-212212</ArticleId><ArticleId IdType="pubmed">31383776</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham B.S. Vaccine development for respiratory syncytial virus. Curr. Opin. Virol. 2017;23:107–112. doi: 10.1016/j.coviro.2017.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2017.03.012</ArticleId><ArticleId IdType="pmc">PMC5653266</ArticleId><ArticleId IdType="pubmed">28525878</ArticleId></ArticleIdList></Reference><Reference><Citation>Green C.A., Drysdale S.B., Pollard A.J., Sande C.J. Vaccination against Respiratory Syncytial Virus. Interdiscip. Top. Gerontol. Geriatr. 2020;43:182–192. doi: 10.1159/000504477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000504477</ArticleId><ArticleId IdType="pubmed">32305982</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruckwardt T.J., Morabito K.M., Graham B.S. Immunological Lessons from Respiratory Syncytial Virus Vaccine Development. Immunity. 2019;51:429–442. doi: 10.1016/j.immuni.2019.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.08.007</ArticleId><ArticleId IdType="pubmed">31533056</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Vaccine Tracker.  [(accessed on 6 November 2023)].  Available online:  https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker.</Citation></Reference><Reference><Citation>Clinical Trials.  [(accessed on 6 November 2023)].  Available online:  https://www.mayo.edu/research/clinical-trials/cls-20147700#moreinfo.</Citation></Reference><Reference><Citation>Dose Ranging Study of ALX-0171 in Infants Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Infection (Respire)  [(accessed on 6 November 2023)]; Available online:  https://classic.clinicaltrials.gov/ct2/show/NCT02979431.</Citation></Reference><Reference><Citation>Vainionpaa R., Hyypia T. Biology of parainfluenza viruses. Clin. Microbiol. Rev. 1994;7:265–275. doi: 10.1128/CMR.7.2.265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.7.2.265</ArticleId><ArticleId IdType="pmc">PMC358320</ArticleId><ArticleId IdType="pubmed">8055470</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato M., Wright P.F. Current status of vaccines for parainfluenza virus infections. Pediatr. Infect. Dis. J. 2008;27((Suppl. 10)):S123–S125. doi: 10.1097/INF.0b013e318168b76f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0b013e318168b76f</ArticleId><ArticleId IdType="pubmed">18820572</ArticleId></ArticleIdList></Reference><Reference><Citation>Chemaly R.F., Marty F.M., Wolfe C.R., Lawrence S.J., Dadwal S., Soave R., Farthing J., Hawley S., Montanez P., Hwang J., et al. DAS181 Treatment of Severe Lower Respiratory Tract Parainfluenza Virus Infection in Immunocompromised Patients: A Phase 2 Randomized, Placebo-Controlled Study. Clin. Infect. Dis. 2021;73:e773–e781. doi: 10.1093/cid/ciab113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab113</ArticleId><ArticleId IdType="pmc">PMC8326557</ArticleId><ArticleId IdType="pubmed">33569576</ArticleId></ArticleIdList></Reference><Reference><Citation>Karron R.A., Herbert K., Wanionek K., Schmidt A.C., Schaap-Nutt A., Collins P.L., Buchholz U.J. Evaluation of a Live-Attenuated Human Parainfluenza Virus Type 2 Vaccine in Adults and Children. J. Pediatr. Infect. Dis. Soc. 2023;12:173–176. doi: 10.1093/jpids/piac137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piac137</ArticleId><ArticleId IdType="pmc">PMC10112673</ArticleId><ArticleId IdType="pubmed">36594442</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt A.C., Schaap-Nutt A., Bartlett E.J., Schomacker H., Boonyaratanakornkit J., Karron R.A., Collins P.L. Progress in the development of human parainfluenza virus vaccines. Expert. Rev. Respir. Med. 2011;5:515–526. doi: 10.1586/ers.11.32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/ers.11.32</ArticleId><ArticleId IdType="pmc">PMC3503243</ArticleId><ArticleId IdType="pubmed">21859271</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasman L.M. Engineering the common cold to be a live-attenuated SARS-CoV-2 vaccine. Front. Immunol. 2022;13:871463. doi: 10.3389/fimmu.2022.871463.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.871463</ArticleId><ArticleId IdType="pmc">PMC9516391</ArticleId><ArticleId IdType="pubmed">36189239</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung R.Y., Yin J., Oppenheimer S.J., Tam J.S., Lau J. Treatment of respiratory syncytial virus infection with recombinant interferon alfa-2a. Arch. Dis. Child. 1993;69:440–442. doi: 10.1136/adc.69.4.440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.69.4.440</ArticleId><ArticleId IdType="pmc">PMC1029552</ArticleId><ArticleId IdType="pubmed">8259875</ArticleId></ArticleIdList></Reference><Reference><Citation>Douglas R.M., Moore B., Miles H.B., Pinnock C.B. Could preventive intranasal interferon lower the morbidity in children prone to respiratory illness? Med. J. Aust. 1990;152:524–528. doi: 10.5694/j.1326-5377.1990.tb125353.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/j.1326-5377.1990.tb125353.x</ArticleId><ArticleId IdType="pmc">PMC7168430</ArticleId><ArticleId IdType="pubmed">1692602</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Nakib W., Higgins P.G., Barrow I., Batstone G., Tyrrell D.A. Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J. Antimicrob. Chemother. 1987;20:893–901. doi: 10.1093/jac/20.6.893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/20.6.893</ArticleId><ArticleId IdType="pmc">PMC7110079</ArticleId><ArticleId IdType="pubmed">3440773</ArticleId></ArticleIdList></Reference><Reference><Citation>Gwaltney J.M., Jr. Combined antiviral and antimediator treatment of rhinovirus colds. J. Infect. Dis. 1992;166:776–782. doi: 10.1093/infdis/166.4.776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/166.4.776</ArticleId><ArticleId IdType="pubmed">1326582</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacobucci G. COVID-19: Runny nose, headache, and fatigue are commonest symptoms of omicron, early data show. BMJ. 2021;375:n3103. doi: 10.1136/bmj.n3103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n3103</ArticleId><ArticleId IdType="pubmed">34916215</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohkubo K., Lee C.H., Baraniuk J.N., Merida M., Hausfeld J.N., Kaliner M.A. Angiotensin-converting enzyme in the human nasal mucosa. Am. J. Respir. Cell Mol. Biol. 1994;11:173–180. doi: 10.1165/ajrcmb.11.2.8049077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/ajrcmb.11.2.8049077</ArticleId><ArticleId IdType="pubmed">8049077</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>